The global bronchoscopes market accounted for USD 0.582 billion in 2023 and is expected to reach at USD 1.54 billion by 2034 with a CAGR of 9.25% during the forecast period 2024-2034. Growing incidence of respiratory conditions such as COPD (Chronic Obstructive Pulmonary Disease), asthma, & lung cancer, surge in efforts to enhance reimbursement policies, rising technological advancements, increasing investment in bronchoscopy facilities, surge in the elderly population, growing regulatory approvals for new devices, and rising introduction of new bronchoscopes are some of the key factors boosting the market growth.
Rising introduction of new bronchoscopes is predicted to boost the market growth during the forecast period. Bronchoscopes are predominantly utilized to evaluate and treat various respiratory and airway disorders. These devices facilitate the detection and diagnosis of conditions such as blockages, chronic obstructive pulmonary diseases (COPD), bronchopulmonary hemorrhage, tumors, airway stenosis, and inflammatory conditions.For instance, in July 2023, Ambu introduced the Ambu VivaSight 2 SLT, their newest offering for intubation and one lung ventilation (OLV) procedures, thus finalizing their distinct VivaSight portfolio for one lung ventilation. This range includes tubes with built-in cameras, an endobronchial blocker, and various sizes of single-use bronchoscopes.
By type, flexible was the highest revenue-grossing segment in the global bronchoscopes market in 2023. Fiber optic bronchoscopy provides numerous advantages, including superior video quality, notable cost-effectiveness, and convenience for both physicians and patients. Its high-resolution videos enable the easy detection of tumors and infections within deeper bronchial levels. Additionally, rigid is predicted to grow at the fastest CAGR during the forecast period owing to the growing adoption in surgeries with severe conditions and increasing collaborations among market players. For instance, in May 2022, Olympus disclosed a strategic co-marketing partnership with Bracco Diagnostics Inc., a U.S. branch of Bracco Imaging S.p.A., a prominent global entity in the diagnostic imaging sector. Bracco Imaging S.p.A. is recognized for its innovation and provision of novel solutions for medical and surgical procedures.
By use, reusable was the highest revenue-grossing segment in the global bronchoscopes market in 2023. Reusable flexible bronchoscopes continue to be utilized for advanced diagnostic and therapeutic procedures because of their maneuverability, ease of handling, deflection angle, image quality, and larger channel size for passing additional instruments, offering benefits such as versatility and cost-effectiveness. Additionally, disposable is predicted to grow at the fastest CAGR during the forecast period owing to the factors such as cost-effectiveness, prevention of cross-contamination, immediate availability, & elimination of reprocessing expenses, and growing introduction of innovative devices by market players. For instance, in February 2022, Olympus has secured the new Vizient Single-Use Visualization Devices contract for its range of single-use bronchoscopes. The portfolio includes five high-quality H-SteriScope single-use bronchoscopes, designed to complement Olympus' existing reusable bronchoscope lineup available under Vizient's contract portfolio.
By application, diagnosis was the highest revenue-grossing segment in the global bronchoscopes market in 2023 owing to the rise in respiratory illnesses, expanding utilization for lung disease diagnosis, and surge in the introduction of new products. Additionally, treatments is predicted to grow at the fastest CAGR during the forecast period owing to the increasing advancements in bronchoscopy device technology, rise in the occurrence of airway lesions & lung parenchyma issues, and growing number of approvals from regulatory agencies. For instance, in 2022, Ethicon, a Johnson & Johnson MedTech company, has announced that the FDA has granted 510(k) approval for its Monarch robotic surgery platform. The FDA has authorized Ethicon's subsidiary, Auris Health, to utilize Monarch for endourological procedures. According to company representatives, it is currently the first and sole adaptable multispecialty robotic solution approved for both urology and bronchoscopy applications.
By end-user, hospital was the highest revenue-grossing segment in the global bronchoscopes market in 2023 owing to a significant occurrence of respiratory conditions among hospitalized patients receiving treatment or care, high volume of asthma & other lung diseases managed in emergency departments, and hospitals are increasingly embracing innovative technologies. For instance, in March 2023, Thoracic surgeons at the Chinese University of Hong Kong (CUHK) have led the way in utilizing robotic-assisted bronchoscopic microwave ablation (RBMA) for the treatment of lung metastases, aiming to preserve healthy lung tissue. Additionally, ambulatory surgical centers is predicted to grow at the fastest CAGR during the forecast period owing to the availability of proficient personnel for conducting bronchoscopy procedures and increase in technological advancements.
North America region is anticipated for the highest revenue share during the forecast period owing to the rise in lung cancer cases, significant presence of established industry players, increase in favorable reimbursement policies from state & federal governments, growing elderly population, and uptick in approvals from regulatory agencies. For instance, in July 2022, Ambu Inc. announced that the Ambu aScopeTM 5 Broncho, a range of single-use, sterile bronchoscopes, has obtained 510(k) regulatory clearance from the FDA in the United States. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing technological advancements, increase in healthcare spending, surge in the prevalence of chronic obstructive pulmonary diseases, and growing introduction of advanced medical devices. For instance, in September 2022, At the European Respiratory Society (ERS) International Congress in Barcelona, Fujifilm revealed the enhancement of its pulmonology solutions collection by introducing the EB-710P Slim Bronchoscope. Additionally, the expanded product lineup encompasses the FDR Nano X-ray system, a digital X-ray machine characterized by its lightweight, compact design, and portability.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Rising introduction of new bronchoscopes is predicted to boost the market growth during the forecast period. Bronchoscopes are predominantly utilized to evaluate and treat various respiratory and airway disorders. These devices facilitate the detection and diagnosis of conditions such as blockages, chronic obstructive pulmonary diseases (COPD), bronchopulmonary hemorrhage, tumors, airway stenosis, and inflammatory conditions.For instance, in July 2023, Ambu introduced the Ambu VivaSight 2 SLT, their newest offering for intubation and one lung ventilation (OLV) procedures, thus finalizing their distinct VivaSight portfolio for one lung ventilation. This range includes tubes with built-in cameras, an endobronchial blocker, and various sizes of single-use bronchoscopes.
By type, flexible was the highest revenue-grossing segment in the global bronchoscopes market in 2023. Fiber optic bronchoscopy provides numerous advantages, including superior video quality, notable cost-effectiveness, and convenience for both physicians and patients. Its high-resolution videos enable the easy detection of tumors and infections within deeper bronchial levels. Additionally, rigid is predicted to grow at the fastest CAGR during the forecast period owing to the growing adoption in surgeries with severe conditions and increasing collaborations among market players. For instance, in May 2022, Olympus disclosed a strategic co-marketing partnership with Bracco Diagnostics Inc., a U.S. branch of Bracco Imaging S.p.A., a prominent global entity in the diagnostic imaging sector. Bracco Imaging S.p.A. is recognized for its innovation and provision of novel solutions for medical and surgical procedures.
By use, reusable was the highest revenue-grossing segment in the global bronchoscopes market in 2023. Reusable flexible bronchoscopes continue to be utilized for advanced diagnostic and therapeutic procedures because of their maneuverability, ease of handling, deflection angle, image quality, and larger channel size for passing additional instruments, offering benefits such as versatility and cost-effectiveness. Additionally, disposable is predicted to grow at the fastest CAGR during the forecast period owing to the factors such as cost-effectiveness, prevention of cross-contamination, immediate availability, & elimination of reprocessing expenses, and growing introduction of innovative devices by market players. For instance, in February 2022, Olympus has secured the new Vizient Single-Use Visualization Devices contract for its range of single-use bronchoscopes. The portfolio includes five high-quality H-SteriScope single-use bronchoscopes, designed to complement Olympus' existing reusable bronchoscope lineup available under Vizient's contract portfolio.
By application, diagnosis was the highest revenue-grossing segment in the global bronchoscopes market in 2023 owing to the rise in respiratory illnesses, expanding utilization for lung disease diagnosis, and surge in the introduction of new products. Additionally, treatments is predicted to grow at the fastest CAGR during the forecast period owing to the increasing advancements in bronchoscopy device technology, rise in the occurrence of airway lesions & lung parenchyma issues, and growing number of approvals from regulatory agencies. For instance, in 2022, Ethicon, a Johnson & Johnson MedTech company, has announced that the FDA has granted 510(k) approval for its Monarch robotic surgery platform. The FDA has authorized Ethicon's subsidiary, Auris Health, to utilize Monarch for endourological procedures. According to company representatives, it is currently the first and sole adaptable multispecialty robotic solution approved for both urology and bronchoscopy applications.
By end-user, hospital was the highest revenue-grossing segment in the global bronchoscopes market in 2023 owing to a significant occurrence of respiratory conditions among hospitalized patients receiving treatment or care, high volume of asthma & other lung diseases managed in emergency departments, and hospitals are increasingly embracing innovative technologies. For instance, in March 2023, Thoracic surgeons at the Chinese University of Hong Kong (CUHK) have led the way in utilizing robotic-assisted bronchoscopic microwave ablation (RBMA) for the treatment of lung metastases, aiming to preserve healthy lung tissue. Additionally, ambulatory surgical centers is predicted to grow at the fastest CAGR during the forecast period owing to the availability of proficient personnel for conducting bronchoscopy procedures and increase in technological advancements.
North America region is anticipated for the highest revenue share during the forecast period owing to the rise in lung cancer cases, significant presence of established industry players, increase in favorable reimbursement policies from state & federal governments, growing elderly population, and uptick in approvals from regulatory agencies. For instance, in July 2022, Ambu Inc. announced that the Ambu aScopeTM 5 Broncho, a range of single-use, sterile bronchoscopes, has obtained 510(k) regulatory clearance from the FDA in the United States. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing technological advancements, increase in healthcare spending, surge in the prevalence of chronic obstructive pulmonary diseases, and growing introduction of advanced medical devices. For instance, in September 2022, At the European Respiratory Society (ERS) International Congress in Barcelona, Fujifilm revealed the enhancement of its pulmonology solutions collection by introducing the EB-710P Slim Bronchoscope. Additionally, the expanded product lineup encompasses the FDR Nano X-ray system, a digital X-ray machine characterized by its lightweight, compact design, and portability.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Type, Use, Application, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Bronchoscopes Market Report 2023 - 2034
Bronchoscopes Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Rigid
- Flexible
- Fiberoptic
- Hybrid
- Video
Bronchoscopes Market Analysis & Forecast by Use 2023 - 2034 (Revenue USD Bn)
- Disposable
- Reusable
Bronchoscopes Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Treatments
- Diagnosis
Bronchoscopes Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Bronchoscopes Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Bronchoscopes Market: Type Estimates & Trend Analysis
8. Bronchoscopes Market: Use Estimates & Trend Analysis
9. Bronchoscopes Market: Application Estimates & Trend Analysis
10. Bronchoscopes Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Bronchoscopes Market
13. Europe Global Bronchoscopes Market
14. Asia Pacific Global Bronchoscopes Market
15. Latin America Global Bronchoscopes Market
16. MEA Global Bronchoscopes Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Fujifilm Holdings Corporation
- Olympus Corporation
- Cogentix Medical
- Ambu A/s
- Teleflex Incorporated
- Karl Storz
- Boston Scientific Corporation
